Zucknick was devastated
Patients should confirm with their provider exactly how to measure doses and which measurement unit applies to their specific product
These results are in line with those of Kamel et al
Under 503A, there may continue to be specific, limited situations where compounding tirzepatide and semaglutide can take place, if a healthcare provider determines there is either a significant difference or a clinical difference between the compounded version and the FDA-approved product
Stewardship is not a treatment restriction Yet another misconception is that adding clinical oversight and responsible use, or stewardship, to a GLP-1 benefit will make access harder or increase cost
If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
)
